SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jad who wrote (2395)4/15/1998 10:43:00 AM
From: ENOTS  Read Replies (1) of 3725
 
Well no big bad news, just the same old losses,.....I like this
**********************************************************************''A key objective for the 1998 fiscal year will be to rationalize the role of our HeartScan subsidiary
in supporting Ultrafast CT scanner sales, given Imatron's assumption of worldwide product
distribution rights from Siemens. We expect that this strategic refocus will include, among other
actions, a search for a corporate or joint venture partner or acquirer for HeartScan.
**********************************************************************
8 plus Mil. loss in heartscan! large part of the -.15 sometimes the market likes a loss of less! disturbing fact, but the fact is still losing!
********************************************************************
The Medical Community is really slow and methodical in wrapping their arms around any new technology, it is almost criminal! Well what say you TA people? Do we move up a little and Fall back? or WHAT??????
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News